James Holah
Product & Strategy Director
James is a seasoned professional with over two decades of experience in the life sciences industry. His journey began at IQVIA in June 2022, as part of the EMEA Technology team before making a strategic move to PharmaReview in April 2025. Throughout his career, James has been a dynamic force, seamlessly collaborating across medical and commercial roles, and gaining unique insights into the industry's diverse landscape.
His expertise in content approval systems, both as a user and commercial signatory, has seen him successfully roll out global systems that streamline processes and enhance efficiency. His ability to deliver in various roles has equipped him with a broad spectrum of knowledge.
At Pharmareview, James is on a mission to drive innovation, to elevate the customer experience, taking Pharma Review to new heights, and ensuring that the business remains at the forefront of the industry.